NCT03732937

Brief Summary

\- Different parameters are used to estimate gestational age AC, HC , BPD and FL

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
700

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 5, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 7, 2018

Completed
9 days until next milestone

Study Start

First participant enrolled

November 16, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2019

Completed
Last Updated

January 9, 2019

Status Verified

January 1, 2019

Enrollment Period

6 months

First QC Date

November 5, 2018

Last Update Submit

January 8, 2019

Conditions

Gestational Age and Weight Conditions

Outcome Measures

Primary Outcomes (1)

  • The number of participants who will be exactly dated by TCD in comparison to LMP

    The number of participants who will be exactly dated by TCD in comparison to LMP in weeks

    within 4 months

Study Arms (2)

Control group

Pregnant ladies with no medical disorders from 16 weeks till term

Diagnostic Test: Ultrasonography

case group

Pregnant ladies with medical disorders from 16 weeks till term

Diagnostic Test: Ultrasonography

Interventions

UltrasonographyDIAGNOSTIC_TEST

Ultrasonography with biometry and TCD measurement

Control groupcase group

Eligibility Criteria

Age19 Years - 42 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant females
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

pregnant ladies with GA between 16 - 40 weeks

You may qualify if:

  • pregnant ladies with GA between 16 - 40 weeks

You may not qualify if:

  • pregnant ladies with GA less than 16 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Algazeerah and Kasralainy hospital

Giza, Egypt

RECRUITING

MeSH Terms

Interventions

Ultrasonography

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Mahmoud Alalfy, PhD

    Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mahmoud Alalfy, PhD

CONTACT

01002611058mahmoudalalfy@ymail.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
4 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, Researcher , National Research centre and Consultant of Obstetrics and Gynecology in Aljazeerah hospital

Study Record Dates

First Submitted

November 5, 2018

First Posted

November 7, 2018

Study Start

November 16, 2018

Primary Completion

May 1, 2019

Study Completion

May 20, 2019

Last Updated

January 9, 2019

Record last verified: 2019-01

Locations

EG(1)